Travere Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Travere Therapeutics's balance sheet done over the years? Its assets were worth $788,913,000 last year, which is more than in the previous period. 75% of Travere Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $588,103,000, which means an decrease by -7% compared compared to last year.
Debt to Assets
| 2014 | 135470972 | 172.72M | 127.5% |
|---|---|---|---|
| 2015 | 512400000 | 212.42M | 41.46% |
| 2016 | 525282000 | 217.51M | 41.41% |
| 2017 | 520346000 | 227.21M | 43.67% |
| 2018 | 709160000 | 390.90M | 55.12% |
| 2019 | 604800000 | 383.60M | 63.43% |
| 2020 | 607439000 | 396.22M | 65.23% |
| 2021 | 776633000 | 474.52M | 61.1% |
| 2022 | 672585000 | 629.73M | 93.63% |
| 2023 | 788913000 | 588.10M | 74.55% |
TVTX Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 58.17M | 61.68M | 165.75M | 84.77M | 62.43M | 102.87M | 99.39M | 41.00M | 37.80M | 18.20M |
Short term investments | 508.67M | 388.55M | 387.12M | 276.81M | 336.08M | 368.66M | 201.23M | 214.87M | 191.79M | 9.55M |
Net receivables | 21.17M | 16.64M | 16.16M | 33.06M | 18.04M | 14.49M | 13.87M | 65.35M | 59.30M | 7.95M |
Inventory | 9.41M | 6.92M | 7.31M | 7.60M | 6.08M | 5.61M | 5.35M | 2.82M | 2.53M | 800.50K |
Other current assets | 19.33M | 12.62M | 6.47M | 8.14M | 6.41M | 4.02M | 8.79M | 8.29M | 10.48M | 813.36K |
Total current assets | 616.77M | 486.43M | 582.82M | 410.40M | 429.06M | 495.67M | 325.80M | 332.35M | 301.93M | 37.33M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 25.54M | 30.04M | 34.30M | 9.41M | 2.89M | 3.14M | 3.23M | 2.58M | 428K | 670.79K |
Goodwill | 753K | 900K | 936K | 936K | 936K | 936K | 936K | 936K | 936K | 935.93K |
Intangible assets | 103.69M | 145.03M | 148.43M | 153.18M | 157.2M | 186.69M | 184.81M | 182.04M | 161.53M | 94.26M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 15M | -16.81M | -6.42M | 21.24M | -140.81M |
Other non-current assets | 42.15M | 11.06M | 11.06M | 33.48M | 14.70M | -24.99M | 5.55M | 7.36M | 1.99M | 1.92M |
Total non-current assets | 172.13M | 186.14M | 193.80M | 197.03M | 175.73M | 213.48M | 194.53M | 192.93M | 210.46M | 98.13M |
Total assets | 788.91M | 672.58M | 776.63M | 607.43M | 604.8M | 709.16M | 520.34M | 525.28M | 512.4M | 135.47M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 7.09M | 11.97M | 16.26M | -357K | -2.61M | 49.69M | 0 | 0 | 0 | 28.88M |
Short term debt | 9.81M | 4.43M | 3.90M | 357K | 2.61M | 22.45M | 0 | 0 | 0 | 40.48M |
Total current liabilities | 177.90M | 142.16M | 124.08M | 92.66M | 95.44M | 104.62M | 85.66M | 83.26M | 85.79M | 107.53M |
| Non-current liabilities: | ||||||||||
Long term debt | 399.87M | 403.05M | 258.07M | 215.33M | 204.86M | 195.09M | 45.07M | 44.42M | 43.76M | 43.28M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 8.48M | 73.58M | 71.97M | 88.22M | 83.29M | 91.19M | 96.46M | 83.40M | 81.54M | 21.89M |
Total non-current liabilities | 410.19M | 487.57M | 350.43M | 303.56M | 288.15M | 286.28M | 141.54M | 134.25M | 126.63M | 65.18M |
Total liabilities | 588.10M | 629.73M | 474.52M | 396.22M | 383.60M | 390.90M | 227.21M | 217.51M | 212.42M | 172.72M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |